Basic Information
| RNALocate ID: | RLID-D:11000310 |
| RNA Symbol: | hsa-miR-148a-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-148a-3p |
| RNA ID: | miRBase:MIMAT0000243 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001570 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11001317 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001318 | Exosome | Breast milk | 22211110 |
| RLID:11001319 | Exosome | Brain tissue | 23382797 |
| RLID:11001320 | Exosome | Plasma | 23663360 |
| RLID:11001321 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001322 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
| RLID:11001323 | Exosome | Saliva | 25376581 |
| RLID:11001324 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001325 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001326 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000041 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-148a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-15916 |
| MNDR | hsa-miR-148a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-15917 |
| MNDR | hsa-miR-148a-3p | Oral squamous cell carcinoma | MNDR-E-MI-15918 |
| MNDR | hsa-miR-148a-3p | Medulloblastoma | MNDR-E-MI-15919 |
| MNDR | hsa-miR-148a-3p | Lymphoma | MNDR-E-MI-15920 |
| MNDR | hsa-miR-148a-3p | Lymphoma non-hodgkin | MNDR-E-MI-15921 |
| MNDR | hsa-miR-148a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-15922 |
| MNDR | hsa-miR-148a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-15923 |
| MNDR | hsa-miR-148a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-15924 |
| MNDR | hsa-miR-148a-3p | Breast cancer luminal | MNDR-E-MI-15925 |
| MNDR | hsa-miR-148a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-15926 |
| MNDR | hsa-miR-148a-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-15927 |
| MNDR | hsa-miR-148a-3p | Dermatomyositis | MNDR-E-MI-15928 |
| MNDR | hsa-miR-148a-3p | Castration-resistant prostate cancer | MNDR-E-MI-15929 |
| MNDR | hsa-miR-148a-3p | Gastric cancer | MNDR-E-MI-15930 |
| MNDR | hsa-miR-148a-3p | Alzheimer disease | MNDR-E-MI-15931 |
| MNDR | hsa-miR-148a-3p | Intracranial aneurysm | MNDR-E-MI-15932 |
| MNDR | hsa-miR-148a-3p | Bladder cancer | MNDR-E-MI-15933 |
| MNDR | hsa-miR-148a-3p | Esophageal carcinoma | MNDR-E-MI-15934 |
| MNDR | hsa-miR-148a-3p | Dysautonomia familial | MNDR-E-MI-15935 |
| MNDR | hsa-miR-148a-3p | Myotonic dystrophy | MNDR-E-MI-15936 |
| MNDR | hsa-miR-148a-3p | Muscular dystrophy duchenne | MNDR-E-MI-15937 |
| MNDR | hsa-miR-148a-3p | Leukemia | MNDR-E-MI-15938 |
| MNDR | hsa-miR-148a-3p | Huntington disease | MNDR-E-MI-15939 |
| MNDR | hsa-miR-148a-3p | Chorea | MNDR-E-MI-15940 |
| MNDR | hsa-miR-148a-3p | Cardiovascular disease | MNDR-E-MI-15941 |
| MNDR | hsa-miR-148a-3p | Parkinson disease | MNDR-E-MI-15942 |
| MNDR | hsa-miR-148a-3p | Breast cancer | MNDR-E-MI-15943 |
| MNDR | hsa-miR-148a-3p | Neuroendocrine neoplasia | MNDR-E-MI-15944 |
| MNDR | hsa-miR-148a-3p | Pituitary neoplasms | MNDR-E-MI-15945 |
| MNDR | hsa-miR-148a-3p | Pancreatic cancer | MNDR-E-MI-15946 |
| MNDR | hsa-miR-148a-3p | Intrahepatic cholestasis | MNDR-E-MI-15947 |
| MNDR | hsa-miR-148a-3p | Melanoma | MNDR-E-MI-15948 |
| MNDR | hsa-miR-148a-3p | Rectum adenocarcinoma | MNDR-E-MI-15949 |
| MNDR | hsa-miR-148a-3p | Nephroblastoma | MNDR-E-MI-15950 |
| MNDR | hsa-miR-148a-3p | Colon cancer | MNDR-E-MI-15951 |
| MNDR | hsa-miR-148a-3p | Ischemic attack transient | MNDR-E-MI-15952 |
| MNDR | hsa-miR-148a-3p | Colon adenocarcinoma | MNDR-E-MI-15953 |
| MNDR | hsa-miR-148a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-15954 |
| MNDR | hsa-miR-148a-3p | Familial ovarian cancer | MNDR-E-MI-15955 |
| MNDR | hsa-miR-148a-3p | Prostate adenocarcinoma | MNDR-E-MI-15956 |
| MNDR | hsa-miR-148a-3p | Hematologic cancer | MNDR-E-MI-15957 |
| MNDR | hsa-miR-148a-3p | Carcinoma ductal breast | MNDR-E-MI-15958 |
| MNDR | hsa-miR-148a-3p | Glioblastoma | MNDR-E-MI-15959 |
| MNDR | hsa-miR-148a-3p | Glioma | MNDR-E-MI-15960 |
| MNDR | hsa-miR-148a-3p | Nemaline myopathy | MNDR-E-MI-15961 |
| MNDR | hsa-miR-148a-3p | Central nervous system lymphoma | MNDR-E-MI-15962 |
| MNDR | hsa-miR-148a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-15963 |
| MNDR | hsa-miR-148a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-15964 |
| MNDR | hsa-miR-148a-3p | Uterine cancer | MNDR-E-MI-15965 |
| MNDR | hsa-miR-148a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-15966 |
| MNDR | hsa-miR-148a-3p | Pituitary adenoma | MNDR-E-MI-15967 |
| MNDR | hsa-miR-148a-3p | Lung squamous cell carcinoma | MNDR-E-MI-15968 |
| MNDR | hsa-miR-148a-3p | Lung adenocarcinoma | MNDR-E-MI-15969 |
| MNDR | hsa-miR-148a-3p | Acute myocarditis | MNDR-E-MI-15970 |
| MNDR | hsa-miR-148a-3p | Thyroid carcinoma | MNDR-E-MI-15971 |
| MNDR | hsa-miR-148a-3p | Bladder urothelial carcinoma | MNDR-E-MI-15972 |
| MNDR | hsa-miR-148a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-15973 |
| MNDR | hsa-miR-148a-3p | Skin cancer | MNDR-E-MI-15974 |
| MNDR | hsa-miR-148a-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-15975 |
| MNDR | hsa-miR-148a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-15976 |
| MNDR | hsa-miR-148a-3p | Renal clear cell carcinoma | MNDR-E-MI-15977 |
| MNDR | hsa-miR-148a-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-15978 |
| MNDR | hsa-miR-148a-3p | Cholangiocarcinoma | MNDR-E-MI-15979 |
| MNDR | hsa-miR-148a-3p | Esophageal cancer | MNDR-E-MI-15980 |
| MNDR | hsa-miR-148a-3p | Liver cirrhosis | MNDR-E-MI-15981 |
| MNDR | hsa-miR-148a-3p | Lung small cell carcinoma | MNDR-E-MI-15982 |
| MNDR | hsa-miR-148a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-15983 |
| MNDR | hsa-miR-148a-3p | Aortic valve disease | MNDR-E-MI-15984 |
| MNDR | hsa-miR-148a-3p | Breast invasive carcinoma | MNDR-E-MI-15985 |
| MNDR | hsa-miR-148a-3p | Early hepatocellular carcinoma | MNDR-E-MI-15986 |
| MNDR | hsa-miR-148a-3p | Familiar ovarian carcinoma | MNDR-E-MI-15987 |
| MNDR | hsa-miR-148a-3p | B-cell lymphoma | MNDR-E-MI-15988 |
| MNDR | hsa-miR-148a-3p | Rheumatoid arthritis | MNDR-E-MI-15989 |
| MNDR | hsa-miR-148a-3p | T-cell leukemia | MNDR-E-MI-15990 |
| MNDR | hsa-miR-148a-3p | Malignant pleural mesothelioma | MNDR-E-MI-15991 |
| MNDR | hsa-miR-148a-3p | Hodgkin lymphoma | MNDR-E-MI-15992 |
| MNDR | hsa-miR-148a-3p | Burkitt lymphoma | MNDR-E-MI-15993 |
| MNDR | hsa-miR-148a-3p | Neuromyelitis optica | MNDR-E-MI-15994 |
| MNDR | hsa-miR-148a-3p | Skin cutaneous melanoma | MNDR-E-MI-15995 |
| MNDR | hsa-miR-148a-3p | Skin melanoma | MNDR-E-MI-15996 |
| MNDR | hsa-miR-148a-3p | Acute myelocytic leukemia | MNDR-E-MI-15997 |
| MNDR | hsa-miR-148a-3p | Colorectal cancer | MNDR-E-MI-15998 |
| MNDR | hsa-miR-148a-3p | Multiple myeloma | MNDR-E-MI-15999 |
| MNDR | hsa-miR-148a-3p | Acute lymphocytic leukemia | MNDR-E-MI-16000 |
| MNDR | hsa-miR-148a-3p | Ependymoma | MNDR-E-MI-16001 |
| MNDR | hsa-miR-148a-3p | Nasopharyngeal cancer | MNDR-E-MI-16002 |
| MNDR | hsa-miR-148a-3p | Epstein-barr virus infections | MNDR-E-MI-16003 |
| MNDR | hsa-miR-148a-3p | Stroke lacunar | MNDR-E-MI-16004 |
| MNDR | hsa-miR-148a-3p | Low grade dysplastic nodule | MNDR-E-MI-16005 |
| MNDR | hsa-miR-148a-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-16006 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR1 | Homo sapiens | RR00038737 |
TOP